Skip to main content

Advertisement

ADVERTISEMENT

Department

News Connection
09/18/2019
Part of their “Building Healthier Communities” initiative, CVS and Aetna recently announced a collaboration project with Unite Us, a social care coordination platform, as one of the first of a series of business programs focused on addressing...
Part of their “Building Healthier Communities” initiative, CVS and Aetna recently announced a collaboration project with Unite Us, a social care coordination platform, as one of the first of a series of business programs focused on addressing...
Part of their “Building...
09/18/2019
First Report Managed Care
News Connection
09/18/2019
In a joint effort, the US Department of Health and Human Services (HHS) and the US Food and Drug Administration (FDA) have announced the Safe Importation Action Plan, a project designed to lower out-of-pocket costs, which defines two possible...
In a joint effort, the US Department of Health and Human Services (HHS) and the US Food and Drug Administration (FDA) have announced the Safe Importation Action Plan, a project designed to lower out-of-pocket costs, which defines two possible...
In a joint effort, the US...
09/18/2019
First Report Managed Care

Advertisement

News Connection
09/18/2019
According to study results published in the New England Journal of Medicine, Medicare spending was lower among providers serving in rural and underserved areas who also participated in ACO shared savings contracts.
According to study results published in the New England Journal of Medicine, Medicare spending was lower among providers serving in rural and underserved areas who also participated in ACO shared savings contracts.
According to study results...
09/18/2019
First Report Managed Care
News Connection
09/18/2019
CAR-T therapy, a cancer treatment that uses a patient’s own genetically-modified immune cells to fight the disease, will now be covered nationwide by Medicare, according to a final decision released by the Centers for Medicare & Medicaid...
CAR-T therapy, a cancer treatment that uses a patient’s own genetically-modified immune cells to fight the disease, will now be covered nationwide by Medicare, according to a final decision released by the Centers for Medicare & Medicaid...
CAR-T therapy, a cancer...
09/18/2019
First Report Managed Care
News Connection
09/18/2019
According to a study published in JAMA Internal Medicine, out-of-network is occurring more frequently and becoming more costly in both emergency department (ED) and inpatient settings.
According to a study published in JAMA Internal Medicine, out-of-network is occurring more frequently and becoming more costly in both emergency department (ED) and inpatient settings.
According to a study published...
09/18/2019
First Report Managed Care

Advertisement

Formulary Frontlines®
08/26/2019
Although hemophilia is designated an orphan disease by the FDA because it affects fewer than 200,000 people in the United States, it imposes a significant financial and burden on patients, caregivers, and society.
Although hemophilia is designated an orphan disease by the FDA because it affects fewer than 200,000 people in the United States, it imposes a significant financial and burden on patients, caregivers, and society.
Although hemophilia is...
08/26/2019
First Report Managed Care
Managed Care Q&A
08/26/2019
Scott Vogel, partner and PBM executive, Confidio, recently spoke about the many challenges biosimilars face coming to market and where the market might be heading.
Scott Vogel, partner and PBM executive, Confidio, recently spoke about the many challenges biosimilars face coming to market and where the market might be heading.
Scott Vogel, partner and PBM...
08/26/2019
First Report Managed Care
Managed Care Q&A
08/26/2019
Sonja Quale, PharmD, chief clinical officer and vice president of informatics, Confidio, recently spoke about the many challenges biosimilars face coming to market and where the market might be heading
Sonja Quale, PharmD, chief clinical officer and vice president of informatics, Confidio, recently spoke about the many challenges biosimilars face coming to market and where the market might be heading
Sonja Quale, PharmD, chief...
08/26/2019
First Report Managed Care

Advertisement

Conference Insider
08/26/2019
Gregory O Callahan, MBA, consultant, and Brian N Anderson, MBA, principal, both from Milliman, a consulting and actuarial firm, offer expertise on how to maximize the effectiveness of specialty contracts.
Gregory O Callahan, MBA, consultant, and Brian N Anderson, MBA, principal, both from Milliman, a consulting and actuarial firm, offer expertise on how to maximize the effectiveness of specialty contracts.
Gregory O Callahan, MBA,...
08/26/2019
First Report Managed Care
Conference Insider
08/26/2019
Susan Trieu, PharmD, director of enterprise specialty clinical solutions at MedImpact Health Systems, discusses new therapies in the pipeline and what payers should focus on.
Susan Trieu, PharmD, director of enterprise specialty clinical solutions at MedImpact Health Systems, discusses new therapies in the pipeline and what payers should focus on.
Susan Trieu, PharmD, director of...
08/26/2019
First Report Managed Care

Advertisement